Clinical guideline for male lower urinary tract symptoms

:  This article is a shortened version of the clinical guideline for lower urinary tract symptoms (LUTS), which has been developed in Japan for symptomatic men aged 50 years and over irrespective of presumed diagnoses. The guideline was formed on the PubMed database between 1995 and 2007 and other r...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of urology 2009-10, Vol.16 (10), p.775-790
Hauptverfasser: Homma, Yukio, Araki, Isao, Igawa, Yasuhiko, Ozono, Seiichiro, Gotoh, Momokazu, Yamanishi, Tomonori, Yokoyama, Osamu, Yoshida, Masaki
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 790
container_issue 10
container_start_page 775
container_title International journal of urology
container_volume 16
creator Homma, Yukio
Araki, Isao
Igawa, Yasuhiko
Ozono, Seiichiro
Gotoh, Momokazu
Yamanishi, Tomonori
Yokoyama, Osamu
Yoshida, Masaki
description :  This article is a shortened version of the clinical guideline for lower urinary tract symptoms (LUTS), which has been developed in Japan for symptomatic men aged 50 years and over irrespective of presumed diagnoses. The guideline was formed on the PubMed database between 1995 and 2007 and other relevant sources. The causes of male LUTS are diverse and attributable to diseases/dysfunctions of the lower urinary tract, prostate, nervous system, and other organ systems, with benign prostatic hyperplasia, bladder dysfunction, polyuria, and their combination being most common. The mandatory assessment should comprise medical history, physical examination, urinalysis, and measurement of serum prostate‐specific antigen. Symptom and quality of life questionnaires, bladder diary, residual urine measurement, urine cytology, urine culture, measurement of serum creatinine, and urinary tract ultrasonography would be optional tests. The Core Lower Urinary Tract Symptom Score Questionnaire may be useful in quickly capturing important symptoms. Severe symptoms, pain symptoms, and other clinical problems would indicate urological referral. One should be careful not to overlook underlying diseases such as infection or malignancy. The treatment should be initiated with conservative therapy and/or medicine such as α1‐blockers. Treatment with anticholinergic agents should be reserved only for urologists, considering the risk of urinary retention. The present guideline should help urologists and especially non‐urologists treat men with LUTS.
doi_str_mv 10.1111/j.1442-2042.2009.02369.x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_734077659</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>734077659</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5759-94ef79be677d548b5d403e55e6df360a6e875ec1af9488ee15c0e9bfbd1a84c63</originalsourceid><addsrcrecordid>eNqNkD1PwzAQhi0EoqXwF1A2pgQ78efAgCoorUphaMVoOckFpSRNsRO1_fckpCorXuyT3-fu9CDkERyQ9tyvA0Jp6IeYhkGIsQpwGHEV7M_Q8PRxjoZYEeVLIsIBunJujTGJQiIv0YAoSQijYojkuMg3eWIK77PJU2gL8LLKeqUpwCuqHVivsfnG2INXW5PUnjuU27oq3TW6yEzh4OZ4j9Dq-Wk5fvHnb5Pp-HHuJ0ww5SsKmVAxcCFSRmXMUoojYAx4mkUcGw5SMEiIyRSVEoCwBIOKszglRtKERyN01_fd2uq7AVfrMncJFIXZQNU4LSKKheBMtUnZJxNbOWch01ubl-3mmmDdadNr3dnRnR3dadO_2vS-RW-PQ5q4hPQPPHpqAw99YJcXcPh3Yz2drbpXy_s9n7sa9ife2C_NRSSY_lhMNJu9qnDxzvUy-gEGKYqO</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>734077659</pqid></control><display><type>article</type><title>Clinical guideline for male lower urinary tract symptoms</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Homma, Yukio ; Araki, Isao ; Igawa, Yasuhiko ; Ozono, Seiichiro ; Gotoh, Momokazu ; Yamanishi, Tomonori ; Yokoyama, Osamu ; Yoshida, Masaki</creator><creatorcontrib>Homma, Yukio ; Araki, Isao ; Igawa, Yasuhiko ; Ozono, Seiichiro ; Gotoh, Momokazu ; Yamanishi, Tomonori ; Yokoyama, Osamu ; Yoshida, Masaki ; Japanese Society of Neurogenic Bladder</creatorcontrib><description>:  This article is a shortened version of the clinical guideline for lower urinary tract symptoms (LUTS), which has been developed in Japan for symptomatic men aged 50 years and over irrespective of presumed diagnoses. The guideline was formed on the PubMed database between 1995 and 2007 and other relevant sources. The causes of male LUTS are diverse and attributable to diseases/dysfunctions of the lower urinary tract, prostate, nervous system, and other organ systems, with benign prostatic hyperplasia, bladder dysfunction, polyuria, and their combination being most common. The mandatory assessment should comprise medical history, physical examination, urinalysis, and measurement of serum prostate‐specific antigen. Symptom and quality of life questionnaires, bladder diary, residual urine measurement, urine cytology, urine culture, measurement of serum creatinine, and urinary tract ultrasonography would be optional tests. The Core Lower Urinary Tract Symptom Score Questionnaire may be useful in quickly capturing important symptoms. Severe symptoms, pain symptoms, and other clinical problems would indicate urological referral. One should be careful not to overlook underlying diseases such as infection or malignancy. The treatment should be initiated with conservative therapy and/or medicine such as α1‐blockers. Treatment with anticholinergic agents should be reserved only for urologists, considering the risk of urinary retention. The present guideline should help urologists and especially non‐urologists treat men with LUTS.</description><identifier>ISSN: 0919-8172</identifier><identifier>EISSN: 1442-2042</identifier><identifier>DOI: 10.1111/j.1442-2042.2009.02369.x</identifier><identifier>PMID: 19811547</identifier><language>eng</language><publisher>Melbourne, Australia: Blackwell Publishing Asia</publisher><subject>Algorithms ; benign prostatic hyperplasia ; guideline ; Humans ; lower urinary tract symptoms ; Male ; men ; Prostatism - diagnosis ; Prostatism - etiology ; Prostatism - therapy ; α1-blockers</subject><ispartof>International journal of urology, 2009-10, Vol.16 (10), p.775-790</ispartof><rights>2009 The Japanese Urological Association</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5759-94ef79be677d548b5d403e55e6df360a6e875ec1af9488ee15c0e9bfbd1a84c63</citedby><cites>FETCH-LOGICAL-c5759-94ef79be677d548b5d403e55e6df360a6e875ec1af9488ee15c0e9bfbd1a84c63</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1442-2042.2009.02369.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1442-2042.2009.02369.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1416,27922,27923,45572,45573</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19811547$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Homma, Yukio</creatorcontrib><creatorcontrib>Araki, Isao</creatorcontrib><creatorcontrib>Igawa, Yasuhiko</creatorcontrib><creatorcontrib>Ozono, Seiichiro</creatorcontrib><creatorcontrib>Gotoh, Momokazu</creatorcontrib><creatorcontrib>Yamanishi, Tomonori</creatorcontrib><creatorcontrib>Yokoyama, Osamu</creatorcontrib><creatorcontrib>Yoshida, Masaki</creatorcontrib><creatorcontrib>Japanese Society of Neurogenic Bladder</creatorcontrib><title>Clinical guideline for male lower urinary tract symptoms</title><title>International journal of urology</title><addtitle>Int J Urol</addtitle><description>:  This article is a shortened version of the clinical guideline for lower urinary tract symptoms (LUTS), which has been developed in Japan for symptomatic men aged 50 years and over irrespective of presumed diagnoses. The guideline was formed on the PubMed database between 1995 and 2007 and other relevant sources. The causes of male LUTS are diverse and attributable to diseases/dysfunctions of the lower urinary tract, prostate, nervous system, and other organ systems, with benign prostatic hyperplasia, bladder dysfunction, polyuria, and their combination being most common. The mandatory assessment should comprise medical history, physical examination, urinalysis, and measurement of serum prostate‐specific antigen. Symptom and quality of life questionnaires, bladder diary, residual urine measurement, urine cytology, urine culture, measurement of serum creatinine, and urinary tract ultrasonography would be optional tests. The Core Lower Urinary Tract Symptom Score Questionnaire may be useful in quickly capturing important symptoms. Severe symptoms, pain symptoms, and other clinical problems would indicate urological referral. One should be careful not to overlook underlying diseases such as infection or malignancy. The treatment should be initiated with conservative therapy and/or medicine such as α1‐blockers. Treatment with anticholinergic agents should be reserved only for urologists, considering the risk of urinary retention. The present guideline should help urologists and especially non‐urologists treat men with LUTS.</description><subject>Algorithms</subject><subject>benign prostatic hyperplasia</subject><subject>guideline</subject><subject>Humans</subject><subject>lower urinary tract symptoms</subject><subject>Male</subject><subject>men</subject><subject>Prostatism - diagnosis</subject><subject>Prostatism - etiology</subject><subject>Prostatism - therapy</subject><subject>α1-blockers</subject><issn>0919-8172</issn><issn>1442-2042</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkD1PwzAQhi0EoqXwF1A2pgQ78efAgCoorUphaMVoOckFpSRNsRO1_fckpCorXuyT3-fu9CDkERyQ9tyvA0Jp6IeYhkGIsQpwGHEV7M_Q8PRxjoZYEeVLIsIBunJujTGJQiIv0YAoSQijYojkuMg3eWIK77PJU2gL8LLKeqUpwCuqHVivsfnG2INXW5PUnjuU27oq3TW6yEzh4OZ4j9Dq-Wk5fvHnb5Pp-HHuJ0ww5SsKmVAxcCFSRmXMUoojYAx4mkUcGw5SMEiIyRSVEoCwBIOKszglRtKERyN01_fd2uq7AVfrMncJFIXZQNU4LSKKheBMtUnZJxNbOWch01ubl-3mmmDdadNr3dnRnR3dadO_2vS-RW-PQ5q4hPQPPHpqAw99YJcXcPh3Yz2drbpXy_s9n7sa9ife2C_NRSSY_lhMNJu9qnDxzvUy-gEGKYqO</recordid><startdate>200910</startdate><enddate>200910</enddate><creator>Homma, Yukio</creator><creator>Araki, Isao</creator><creator>Igawa, Yasuhiko</creator><creator>Ozono, Seiichiro</creator><creator>Gotoh, Momokazu</creator><creator>Yamanishi, Tomonori</creator><creator>Yokoyama, Osamu</creator><creator>Yoshida, Masaki</creator><general>Blackwell Publishing Asia</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200910</creationdate><title>Clinical guideline for male lower urinary tract symptoms</title><author>Homma, Yukio ; Araki, Isao ; Igawa, Yasuhiko ; Ozono, Seiichiro ; Gotoh, Momokazu ; Yamanishi, Tomonori ; Yokoyama, Osamu ; Yoshida, Masaki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5759-94ef79be677d548b5d403e55e6df360a6e875ec1af9488ee15c0e9bfbd1a84c63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Algorithms</topic><topic>benign prostatic hyperplasia</topic><topic>guideline</topic><topic>Humans</topic><topic>lower urinary tract symptoms</topic><topic>Male</topic><topic>men</topic><topic>Prostatism - diagnosis</topic><topic>Prostatism - etiology</topic><topic>Prostatism - therapy</topic><topic>α1-blockers</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Homma, Yukio</creatorcontrib><creatorcontrib>Araki, Isao</creatorcontrib><creatorcontrib>Igawa, Yasuhiko</creatorcontrib><creatorcontrib>Ozono, Seiichiro</creatorcontrib><creatorcontrib>Gotoh, Momokazu</creatorcontrib><creatorcontrib>Yamanishi, Tomonori</creatorcontrib><creatorcontrib>Yokoyama, Osamu</creatorcontrib><creatorcontrib>Yoshida, Masaki</creatorcontrib><creatorcontrib>Japanese Society of Neurogenic Bladder</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of urology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Homma, Yukio</au><au>Araki, Isao</au><au>Igawa, Yasuhiko</au><au>Ozono, Seiichiro</au><au>Gotoh, Momokazu</au><au>Yamanishi, Tomonori</au><au>Yokoyama, Osamu</au><au>Yoshida, Masaki</au><aucorp>Japanese Society of Neurogenic Bladder</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinical guideline for male lower urinary tract symptoms</atitle><jtitle>International journal of urology</jtitle><addtitle>Int J Urol</addtitle><date>2009-10</date><risdate>2009</risdate><volume>16</volume><issue>10</issue><spage>775</spage><epage>790</epage><pages>775-790</pages><issn>0919-8172</issn><eissn>1442-2042</eissn><abstract>:  This article is a shortened version of the clinical guideline for lower urinary tract symptoms (LUTS), which has been developed in Japan for symptomatic men aged 50 years and over irrespective of presumed diagnoses. The guideline was formed on the PubMed database between 1995 and 2007 and other relevant sources. The causes of male LUTS are diverse and attributable to diseases/dysfunctions of the lower urinary tract, prostate, nervous system, and other organ systems, with benign prostatic hyperplasia, bladder dysfunction, polyuria, and their combination being most common. The mandatory assessment should comprise medical history, physical examination, urinalysis, and measurement of serum prostate‐specific antigen. Symptom and quality of life questionnaires, bladder diary, residual urine measurement, urine cytology, urine culture, measurement of serum creatinine, and urinary tract ultrasonography would be optional tests. The Core Lower Urinary Tract Symptom Score Questionnaire may be useful in quickly capturing important symptoms. Severe symptoms, pain symptoms, and other clinical problems would indicate urological referral. One should be careful not to overlook underlying diseases such as infection or malignancy. The treatment should be initiated with conservative therapy and/or medicine such as α1‐blockers. Treatment with anticholinergic agents should be reserved only for urologists, considering the risk of urinary retention. The present guideline should help urologists and especially non‐urologists treat men with LUTS.</abstract><cop>Melbourne, Australia</cop><pub>Blackwell Publishing Asia</pub><pmid>19811547</pmid><doi>10.1111/j.1442-2042.2009.02369.x</doi><tpages>16</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0919-8172
ispartof International journal of urology, 2009-10, Vol.16 (10), p.775-790
issn 0919-8172
1442-2042
language eng
recordid cdi_proquest_miscellaneous_734077659
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Algorithms
benign prostatic hyperplasia
guideline
Humans
lower urinary tract symptoms
Male
men
Prostatism - diagnosis
Prostatism - etiology
Prostatism - therapy
α1-blockers
title Clinical guideline for male lower urinary tract symptoms
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T18%3A04%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinical%20guideline%20for%20male%20lower%20urinary%20tract%20symptoms&rft.jtitle=International%20journal%20of%20urology&rft.au=Homma,%20Yukio&rft.aucorp=Japanese%20Society%20of%20Neurogenic%20Bladder&rft.date=2009-10&rft.volume=16&rft.issue=10&rft.spage=775&rft.epage=790&rft.pages=775-790&rft.issn=0919-8172&rft.eissn=1442-2042&rft_id=info:doi/10.1111/j.1442-2042.2009.02369.x&rft_dat=%3Cproquest_cross%3E734077659%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=734077659&rft_id=info:pmid/19811547&rfr_iscdi=true